However, prior efforts using AAV-PCSK9 in immunodeficient humanized NSG mice failed to generate significant atherosclerosis, likely due to insufficient cholesterol elevation (approximately 500 mg/dL [24] vs approximately 1500 mg/dL in the apoE−/− model [25]). This evidence concerns the gene PCSK9 and atherosclerosis.